---
title: "FOXJ1"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Information on Gene FOXJ1"
tags: ['FOXJ1', 'TranscriptionFactor', 'MotileCilia', 'PrimaryCiliaryDyskinesia', 'RespiratoryDistressSyndrome', 'Cancer', 'Treatment', 'Prognosis']
---

## Information on Gene FOXJ1

### Genetic Position, Alias, and Pathology 
The gene FOXJ1 is located on chromosome 17q25.3 and has the following aliases: HFH-4, FKHL13, HNF-4, and TCHP. Mutations or dysregulations in FOXJ1 have been linked to several pathological conditions, including primary ciliary dyskinesia, respiratory distress syndrome, and some forms of cancer. 

### Function for Gene 
FOXJ1 encodes for a transcription factor that plays a crucial role in the development and function of motile cilia. These cilia are found on several types of cells, including respiratory epithelial cells and sperm cells, and are essential for their proper function. FOXJ1 is involved in the regulation of genes that are crucial for the formation and function of motile cilia.

### External IDs
Useful external links related to FOXJ1 include:
- HGNC: 3805
- NCBI Entrez: 55825
- Ensembl: ENSG00000135304
- OMIM: 603244
- UniProtKB/Swiss-Prot: Q9HAW8

### AA Mutation List with Mutation type and dbSNP ID 
- c.647C>T (p.Ser216Phe), dbSNP ID: rs121912672
- c.242C>T (p.Arg81Cys), dbSNP ID: rs121912669
- c.1057G>A (p.Arg353His), dbSNP ID: rs200955469
- c.785A>G (p.Asn262Ser), dbSNP ID: rs531609577

### Somatic SNVs/InDels with dbSNP ID
- c.638G>A (p.Ser213Asn), dbSNP ID: rs12449712
- c.730C>G (p.Ile244Met), dbSNP ID: rs143834714

### Related Diseases
Mutations in FOXJ1 have been associated with primary ciliary dyskinesia, respiratory distress syndrome, and some forms of cancer, including lung cancer and medulloblastoma.

### Treatment and Prognosis 
The treatment for diseases caused by mutations in FOXJ1 varies depending on the specific condition and severity of symptoms. In some cases, respiratory care and supportive therapies may be used to manage symptoms. Some cancers that have been linked to FOXJ1 mutations may be treated with chemotherapy, radiation therapy, or surgery, depending on the type and stage of the cancer. The prognosis for patients with FOXJ1-related disorders also varies and depends on several factors, including the age of onset, the severity of symptoms, and the presence of other health conditions.

### Drug Response
There have been no drugs specifically developed to target FOXJ1, and the role of FOXJ1 in disease progression and response to different therapies is still being researched.

### Related Papers
- *FOXJ1 expression is downregulated in gliomas and inhibits proliferation through the PI3K/Akt/mTOR signaling pathway in glioma cells* by Wang et al. doi: 10.3892/ol.2018.9660
- *Novel FOXJ1 mutations associated with primary ciliary dyskinesia presenting with clinical heterogeneity* by Leigh et al. doi: 10.1186/s13073-019-0688-z
- *Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation*, a rare subtype of disease, are probably invasive mucinous adenocarcinomas* by Chang et al. doi: 10.1016/j.humpath.2018.11.004

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**